SLNO - CIK 0001484565
SOLENO THERAPEUTICS INC (SLNO) reported revenue of $190.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $190.41M | +13024.2% |
| FY 2016 | $1.45M | +138.8% |
| FY 2015 | $607.47K | - |
| FY 2014 | $0.00 | -100.0% |
| FY 2013 | $3.00M | - |
SOLENO THERAPEUTICS INC (SLNO) reported revenue of $190.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, SOLENO THERAPEUTICS INC's revenue grew from $3.00M to $190.41M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.